Intuitive Surgical (ISRG) Stock Price & Analysis
ISRG Stock Chart & Stats
- Day’s Range
- MXN 8,155.00 - MXN 8,225.00
- 52-Week Range
- MXN 5,770.00 - MXN 11,356.00
- Previous Close
- MXN 8,323.13
- Volume
- 440
- Average Volume (3M)
- 270
- Market Cap
- MXN 2.81T
- Enterprise Value
- MXN 139.03B
- Total Cash (Recent Filing)
- MXN 4.04B
- Total Debt (Recent Filing)
- MXN 0
- Price to Earnings (P/E)
- 51.6
- Beta
- -0.05
- Next Earnings
- Jan 26, 2027 (Est.)
- EPS Estimate
- 54.79
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Recurring Revenue Model
The large recurring revenue mix links growth to the installed base and procedure utilization rather than only new system sales. Rising instruments, accessories, and service revenue should support visibility, customer retention, and durable cash generation as adoption expands.
Installed Base And Global Adoption
A broad installed base and global customer network create durable switching benefits through training, service relationships, and procedure familiarity. This footprint also provides a foundation for recurring consumables revenue and further utilization growth across specialties and geographies.
Conservative Balance Sheet
Essentially debt-free finances give Intuitive substantial flexibility to fund product development, international expansion, and capital returns without material refinancing or interest burden. The strong equity base also improves resilience if healthcare demand or operating conditions become less favorable.
Bears Say
Revenue Per Procedure Pressure
Lower revenue per procedure directly challenges the economics of the company’s recurring consumables model, even if procedure volumes continue to grow. The pressure will roll out across countries and may constrain revenue growth and margins until adoption gains or new products offset it.
Regional Growth Headwinds
Slower U.S. procedure growth can moderate utilization of the large domestic installed base, while weaker Chinese conditions may delay placements and consumables expansion. These regional headwinds could make future growth more dependent on international execution and newer procedure categories.
Higher Operating Costs
Faster expense growth can reduce operating leverage if revenue expansion slows or development programs take longer to commercialize. Continued investment is strategically important, but higher compensation, staffing, and prototype costs create a sustained risk to margin progression.
Intuitive Surgical News
ISRG FAQ
What was Intuitive Surgical’s price range in the past 12 months?
What is Intuitive Surgical’s market cap?
When is Intuitive Surgical’s upcoming earnings report date?
How were Intuitive Surgical’s earnings last quarter?
Is Intuitive Surgical overvalued?
Does Intuitive Surgical pay dividends?
What is Intuitive Surgical’s EPS estimate?
How many shares outstanding does Intuitive Surgical have?
What happened to Intuitive Surgical’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Intuitive Surgical?
What is the TipRanks Smart Score and how is it calculated?
Intuitive Surgical Stock Smart Score
Company Description
Intuitive Surgical
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- David J. Rosa
- Employees
- 17,021
- Website
- www.intuitive.com
- Address
- 1020 Kifer Road, Sunnyvale, CA, 94086-5304, US
Intuitive Surgical (ISRG) Earnings & Revenues
ISRG Company Deck
ISRG Earnings Call
Earnings Call SentimentPositive
The call was strongly positive overall. Intuitive reported broad-based procedure, revenue, system placement and installed-base growth, improving non-GAAP profitability, strong adoption of da Vinci 5 and SP, international expansion, favorable clinical evidence and a substantial product and technology pipeline. The main negatives were slower U.S. da Vinci procedure growth, challenging conditions in China, planned 3% to 5% revenue-per-procedure pressure from pricing actions, higher operating expenses and development costs, a $450 million litigation settlement charge and lower GAAP net income.
View all MX:ISRG earnings summariesISRG Net sales Breakdown
- 67.72% U.S.
- 32.28% Outside of U.S
ISRG Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 6 | 4 |
| Technical Analysis | 4 | 6 | 0 |
| Moving Averages | 8 | 0 | 4 |